Cited by 167Parkinson's Disease Mechanisms and TreatmentsNeurotransmitter Receptor Influence on BehaviorTryptophan and brain disorders

The DOI matches its Crossref record; 168 of the 170 references it cites were found in a registry or an index, and 2 are not checked yet.

The Role of Oxidative Stress, Metabolic Compromise, and Inflammation in Neuronal Injury Produced by Amphetamine-Related Drugs of Abuse

Open access

Yamamoto, Bryan K., Raudensky, Jamie·2008·Journal of Neuroimmune Pharmacology

DOI 10.1007/s11481-008-9121-7PMC PMC3955110

Open this paper in CoChat — free account

Abstract

Methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) are amphetamine derivatives with high abuse liability. These amphetamine-related drugs of abuse mediate their effects through the acute activation of both dopaminergic and serotonergic neurons. Long-term abuse of these amphetamine derivatives, however, results in damage to both dopaminergic and serotonergic terminals throughout the brain. This toxicity is mediated in part by oxidative stress, metabolic compromise, and inflammation. The overall objective of this review is to highlight experimental evidence that METH and MDMA increase oxidative stress, produce mitochondrial dysfunction, and increase inflammation that converge and culminate in the long-term toxicity to dopaminergic and serotonergic neurons.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s11481-008-9121-7

Cites

168 of 170 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hydroperoxide metabolism in mammalian organs.
Chance, B., Sies, H., & Boveris, A. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.3.527 · Cited by 5,827
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,676
Peroxynitrite oxidation of sulfhydryls.
Radí, R., Beckman, J. S., Bush, K., & Freeman, B. Α. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64313-7 · Cited by 2,492
Microglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645
Mechanisms of neurotransmitter release by amphetamines: A review
Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.003 · Cited by 1,243
NMDA-dependent superoxide production and neurotoxicity
Lafon‐Cazal, M., Pietri, S., Culcasi, M., & Bockaert, J. (1993) · Nature · doi:10.1038/364535a0 · Cited by 1,183
Reactive microgliosis
Streit, W. J., Walter, S. A., & Pennell, N. A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00069-0 · Cited by 1,096
Metalloproteinases in biology and pathology of the nervous system
Yong, W. V., Power, C., Forsyth, P., & Edwards, D. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081571 · Cited by 1,094
Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine
Thompson, P. M., Hayashi, K. M., Simon, S. L., Geaga, J. A., Hong, M., Sui, Y., Lee, J. Y., Toga, A. W., Ling, W. W., & London, E. D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0713-04.2004 · Cited by 770

Show all 168 references

Sorted by citations

Items 101–167 of 167

Selective Inhibition of PDE4B Reduces Methamphetamine Reinforcement in Two C57BL/6 Substrains
Honeywell, K. M., Doren, E. V., & Szumlinski, K. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094872 · Cited by 12
Involvement of the α1D-adrenergic Receptor in Methamphetamine-Induced Hyperthermia and Neurotoxicity in Rats
Kikuchi-Utsumi, K., Ishizaka, M., Matsumura, N., Watabe, M., Aoyama, K., Sasakawa, N., & Nakaki, T. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9369-9 · Cited by 12
MDMA Administration and Heat Shock Proteins Response: Foreseeing a Molecular Link
Pomara, C., D’Errico, S., Zummo, L., Cappello, F., & Volti, G. L. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110791591445 · Cited by 12
Function of complement factor H and imaging of small molecules by MALDI-MSI in a methamphetamine behavioral sensitization model
Xu, J., Zhang, Z., Liu, R., Sun, Y. X., Liu, H., Nie, Z., Zhao, X., & Pu, X. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.02.002 · Cited by 11
Differential effect of the DRD3 genotype on inflammatory cytokine responses during abstinence in amphetamine-dependent women
Kuo, S.-C., Yeh, Y., Chen, C., Huang, C., Ho, P., Liang, C., Lin, C., Yeh, T., Tsou, C., Yang, B., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.06.023 · Cited by 11
Effectiveness of Traditional Chinese Health-Promoting Exercise as an Adjunct Therapy for Drug Use Disorders: A Systematic Review and Meta-Analysis
Jia, D., Zhou, J., & Xu, Y. (2022) · Journal of Integrative and Complementary Medicine · doi:10.1089/jicm.2021.0285 · Cited by 10
Pharmacological and Molecular Evidence of Neuroprotective Curcumin Effects Against Biochemical and Behavioral Sequels Caused by Methamphetamine: Possible Function of CREB-BDNF Signaling Pathway
Gholami, M., Hozuri, F., Abdolkarimi, S., Mahmoudi, M., Motaghinejad, M., Safari, S., & Sadr, S. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2021.1176.3 · Cited by 10
Parkin regulates drug-taking behavior in rat model of methamphetamine use disorder
SHARMA, A. K., Harutyunyan, A., Schneider, B. L., & Moszczyńska, A. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01387-7 · Cited by 9
The Inflammatory Signals Associated with Psychosis: Impact of Comorbid Drug Abuse
Herrera-Imbroda, J., Flores-López, M., Ruiz-Sastre, P., Sánchez-Lafuente, C. G., Bordallo-Aragón, A., de Fonseca, F. R., & Mayoral, F. (2023) · Biomedicines · doi:10.3390/biomedicines11020454 · Cited by 12
Peripheral Influences of Methamphetamine Neurotoxicity
Blaker, A. L., Northrop, N. A., & Yamamoto, B. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00030-3 · Cited by 11
Self-citation
Sex differences in neurobehavioral consequences of methamphetamine exposure in adult mice
Davis, D., Metzger, D. B., Vann, P. H., Wong, J. M., Subasinghe, K., Gorham, I. K., Phillips, N., Shetty, R. A., Forster, M. J., & Sumien, N. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06122-8 · Cited by 9
Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage
Bavato, F., Stamatakos, S., Ohki, C. M. Y., Seifritz, E., Romualdi, P., Grünblatt, E., & Quednow, B. B. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02502-8 · Cited by 10
Learning and memory effects of neonatal methamphetamine exposure in rats: Role of reactive oxygen species and age at assessment
Jablonski, S. A., Williams, M. T., & Vorhees, C. V. (2017) · Synapse · doi:10.1002/syn.21992 · Cited by 10
Altered serum levels of glial cell line‐derived neurotrophic factor in male chronic schizophrenia patients with tardive dyskinesia
Ye, F., Zhan, Q., Xiao, W., Sha, W., & Zhang, X. (2018) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1727 · Cited by 10
Excessive iron accumulation in the striatum associated with addictive behaviors of medication-overuse headache: a prospective study
Pei, X., Bai, X., Zhang, X., Hu, Z., Wang, W. J., Zhang, X., Zhang, Y., Tang, H., Zhang, Y., Yu, X., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04125-8 · Cited by 8
Linalool attenuates hypothalamus proteome disturbance facilitated by methamphetamine induced neurotoxicity in rats
Koriem, K. M. M., & El-Qady, S. W. B. (2023) · NeuroToxicology · doi:10.1016/j.neuro.2023.09.007 · Cited by 7
Survey of Selective Neurotoxins
Kostrzewa, R. M. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_53 · Cited by 6
Luteolin amends neural neurotransmitters, antioxidants, and inflammatory markers in the cerebral cortex of Adderall exposed rats
Koriem, K. M. M., & El-Soury, N. H. T. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137652 · Cited by 6
Striatal Iron Deposition in Recreational MDMA (Ecstasy) Users
Coray, R. C., Berberat, J., Zimmermann, J., Seifritz, E., Stock, A., Beste, C., Cole, D. M., Unschuld, P. G., & Quednow, B. B. (2023) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2023.02.005 · Cited by 6
Neuropeptide Y suppresses epileptiform discharges by regulating AMPA receptor GluR2 subunit in rat hippocampal neurons
Bu, W., Zhao, W.-Q., Li, W., Dong, C.-Z., Zhang, Z., & Li, Q.-J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6567 · Cited by 6
Enhanced brain distribution of modified aspartoacylase
Poddar, N. K., Zano, S. P., Natarajan, R., Yamamoto, B. K., & Viola, R. E. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.07.002 · Cited by 5
Self-citation
Protective impact of physical exercise on methamphetamine-induced neuroinflammation and neurogenesis impairment depends on the activity level
Smolarz, M., Dębiec, M., Zając, G., Pondel, N., Bogus, K., Kosowska, A., Pieprzyca, E., Orzechowska-Wylęgała, B., Małecki, A., Nowacka-Chmielewska, M. M., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.06.025 · Cited by 4
Dextromethorphan moderates reward deficiency associated with central serotonin transporter availability in 3,4-methylenedioxy-methamphetamine-treated animals
Chiu, C., Ma, K., Huang, E. Y., Chang, H.-W., Weng, S., Yu, T.-H., Farn, S., Kuo, Y.-Y., Huang, W.-S., Cheng, C., et al. (2024) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000001087 · Cited by 4
In silico clinical trial evaluating lisdexamfetamine’s and methylphenidate’s mechanism of action computational models in an attention-deficit/hyperactivity disorder virtual patients’ population
Gutiérrez-Casares, J. R., Quintero, J., Segú-Vergés, C., Monterde, P. R., Pozo-Rubio, T., Coma, M., & Montoto, C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.939650 · Cited by 5
Methamphetamine Neurotoxicity and Neuroinflammatory Processes
Northrop, N. A., & Yamamoto, B. K. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1071-7_21 · Cited by 4
Self-citation
Valerenic acid ameliorates amphetamine-related neurotoxicity by improving hypothalamus tyrosine hydroxylase and histamine-N-methyl transferase enzymes
Koriem, K. M. M., & Naiem, A. H. A. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.101936 · Cited by 3
Acute and Chronic Effects of 3-4, Methylenedioxymethamphetamine on Pyramidal Cells of Hippocampus
Shariati, M. B. H., Mirzaei, F., Asl, S. S., Mosavi, L., & Sohrabi, M. (2014) · Avicenna Journal of Neuro Psych Physiology · doi:10.17795/ajnpp-21812 · Cited by 3
Analysis of Hematological and Biochemical Parameters in Methamphetamine Addicts Compared with Healthy Individuals
Tavasolian, F., Abdollahi, E., Samadi, M., & Vakili, M. (2015) · Medical Laboratory Journal · doi:10.18869/acadpub.mlj.9.4.38 · Cited by 3
Is the 5-iodo-2-aminoindan (5-IAI) the New MDMA?
Coppola, M. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.1000134 · Cited by 3
The Proteomic Landscape of Parkin-Deficient and Parkin-Overexpressing Rat Nucleus Accumbens: An Insight into the Role of Parkin in Methamphetamine Use Disorder
SHARMA, A. K., Atasi, T., Collin, F., Wang, W., Lam, T. T., García-Milian, R., Arroum, T., Pham, L., Hüttemann, M., & Moszczyńska, A. (2025) · Biomolecules · doi:10.3390/biom15070958 · Cited by 3
Advances of neuroimaging findings in medication overuse headache
Wang, X., Zhang, D., Yang, Y., Zheng, J., Jiang, M., & Wang, J. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1715175 · Cited by 2
Methcathinone Neurotoxicity in the Rat Prefrontal Cortex by Integrated Synaptic Changes and Transcriptome Analysis
Zhou, R., Xu, Y., Xu, C., Chen, Z., Lv, J., Yun, K., & Wei, Z. (2025) · Addiction Biology · doi:10.1111/adb.70113 · Cited by 2
Protracted treatment with MDMA induces heteromeric nicotinic receptor up-regulation in the rat brain: An autoradiography study
Ciudad‐Roberts, A., Camarasa, J., Pubill, D., & Escubedo, E. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.02.014 · Cited by 2
3,4-Methylenedioxymethamphetamine (Ecstasy) increases the sensitivity of the contractile apparatus to calcium ions in both malignant hyperthermia-susceptible and normal skeletal muscle fibres
Gerbershagen, M. U., Missler, G., Schütte, J. K., Starosse, A., Graf, B. M., Wappler, F., & Zink, W. (2011) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32834d9427 · Cited by 2
Effects of chronic methamphetamine exposure during early or late phase development in normal and social isolation reared rats
Strauss, L. (2012) · Boloka Institutional Repository (North-west University) · Cited by 2
Apocynin-Tandospirone Derivatives Suppress Methamphetamine-Induced Hyperlocomotion in Rats with Neonatal Exposure to Dizocilpine
Uehara, T., Kurachi, M., Kondo, T., Abe, H., Itoh, H., Sumiyoshi, T., & Suzuki, M. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030366 · Cited by 1
Mental Disorders Are Associated With Leukocytes Telomere Shortening Among People Who Inject Drugs
Durand, M., Nagot, N., Michel, L., Le, S. M., Duong, H. T., Vallo, R., Vizeneux, A., Rapoud, D., Giang, H. T., Quillet, C., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.846844 · Cited by 1
Stimulant Use, HIV, and Plasma Metabolites Among Men
Cherenack, E. M., Larson, M. E., Murray, K. J., Mayer, Z. J., Guerrero, C. R., Broedlow, C. A., Klatt, N. R., & Carrico, A. W. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10223-4 · Cited by 1
Potential Treat-to-Target Approach for Methamphetamine Use Disorder: A Pilot Study of Adenosine 2A Receptor Antagonist With Positron Emission Tomography
Okita, K., Matsumoto, T., Funada, D., Murakami, M., Kato, K., Shigemoto, Y., Sato, N., & Matsuda, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.820447 · Cited by 1
Protection of the PC12 Cells by Nesfatin-1 Against Methamphetamine-Induced Neurotoxicity
Abbasi, Z., Khaksari, M., Shayannia, A., Jafarisani, M., Abbaszadeh‐Goudarzi, G., Nazarnezhad, S., & Rahmati, M. (2022) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-022-10417-x · Cited by 1
Combination effect of ecstasy and curcumin on hematological parameters and serum immunoglobulin levels in early and late phase in male rats
Khalaji, N., Mohammadzadeh, A., Goosheh-derag, M. N., Naderi, R., & Hasanluyi, E. A. (2019) · Physiology and Pharmacology · doi:10.32598/ppj.24.1.50 · Cited by 1
Neuropathological Findings in Drug Abusers
Büttner, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-60531-5_5 · Cited by 1
Down-regulation of CatSper 1 and CatSper 2 genes by methamphetamine
Mansouri, S., Jalali, M., Nikravesh, M. R., & Soukhtanloo, M. (2021) · Toxin Reviews · doi:10.1080/15569543.2020.1868007 · Cited by 1
Neuropathologische Befunde bei Drogenkonsumenten
Büttner, A. (2022) · Springer eBooks · doi:10.1007/978-3-031-13619-1_5 · Cited by 1
Survey of Selective Monoaminergic Neurotoxins Targeting Dopaminergic, Noradrenergic, and Serotoninergic Neurons
Kostrzewa, R. M. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_53 · Cited by 1
Insights Into the Complexity of Methamphetamine Actions in the Brain and Periphery in the Face of a 3rd Methamphetamine Abuse Epidemic
Moszczyńska, A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x1912211213145444 · Cited by 1
Interacció dels derivats amfetamínics amb els receptors nicotínics: Aspectes moleculars i funcionals
Garcia‐Ratés, S. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Contribuição individual dos enatiômeros isolados da 3,4-metilenodioximetanfetamina (MDMA) comparativamente com a mistura racêmica no estresse oxidativo hepático, renal e estriatal de ratos
Bosio, G. (2012) · doi:10.11606/d.9.2012.tde-19062013-160903
Neuropharmacology and toxicology of novel amphetamine-type stimulants
den Hollander, B. (2015)
The Contribution of Ammonia to Methamphetamine Neurotoxicity
Halpin, L. E. (2013) · OhioLink ETD Center (Ohio Library and Information Network)
MRI assessment of brain iron content in methamphetamine users
Berlow, Y. A. (2014) · doi:10.6083/m4028q7c
Glutamate and MDMA Neurobehavioral Toxicity
Anneken, J. H. (2012) · OhioLink ETD Center (Ohio Library and Information Network)
The protective effect of a diet rich in fish oil in an amphetamine toxicity model of Parkinson’s disease
Medvecky, C. M. (2013) · doi:10.7282/t3b27swq
Toxicity of amphetamines: an update Marcia CarvalhoHelena CarmoVera Marisa CostaJoao Paulo Capela • Helena PontesFernando RemiaoFelix CarvalhoMaria de Lourdes Bastos
Carvalho, M. C., Carmo, H., Costa, V. M., Carvalho, F. D., Bastos, M. D. L., & Capela, J. P. (2012)
MDMA and Glutamate
Anneken, J. H., Collins, S. A., Yamamoto, B. K., & Gudelsky, G. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00038-8
Self-citation
Distinct Plasma Cytokine Levels during Early Abstinence in Amphetamine-Dependent Women with and Without Psychosis
Kuo, S.-C., Yeh, Y., Chen, C. Y., Huang, C. C., Shih, M.-C., Yen, C.-H., Ho, P. S., Liang, C., Tsou, C., Yang, B. Z., et al. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000448
Survey of Selective Monoaminergic Neurotoxins Targeting Dopaminergic, Noradrenergic, and Serotoninergic Neurons
Kostrzewa, R. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-71519-9_53-1
Association of Illegal Behavior with GST Isoforms Null Genotyping in Methamphetamine Abuse Cases
Saud, A., Zaid, Z. A. A., Alzahraa, Z. H. A., & Ahmed, R. A. (2024) · International Journal of Pharmaceutical Quality Assurance · doi:10.25258/ijpqa.15.1.23
The Therapeutic Effect of Aerobic Exercise Training on Female Drug Addicts is Achieved by Improving the Community Structure of IntestinalPreprint
Wang, H., Bai, R., Yuan, J., Shen, R., Yang, J., & Yuan, C. (2024) · Research Square · doi:10.21203/rs.3.rs-4191715/v1
Neurotoxicity of Drugs: Adult and Developmental Effects of Drugs on Brain and Behavior
Vorhees, C. V., & Williams, M. T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00294-1
Next-Generation MDMA Analogue SDMA: Pharmacological and Metabolic Insights
Kastner, N., Nadal‐Gratacós, N., Hemmer, S., da Silva, L. A., McKee, J. M. T., Hell, T., Cicalese, G., Holy, M., Kooti, F., Jäntsch, K., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00782
Protective effects of SA-31 in a psychostimulant-induced neurotoxicity model using SH-SY5Y cells
Amankwa, C. E., DebNath, B., Abraham, A., Young, O., Gondi, S. R., Forster, M. J., Shetty, R. A., & Acharya, S. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107399
Effects of MDMA treatment and cessation on sexual behaviour and testicular functions in male sprague-dawley rats
Obembe, O. O., George, E. T., Mustapha, R. A., & Akhigbe, R. E. (2026) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-026-01131-1
Reactive oxygen species alter ex vivo dopaminergic and purinergic signaling and microglia physiology in the nucleus accumbensPreprint
Wadsworth, H. A., Webb, J. A., Taylor, E. B., White, E. R., Ford, L. H., Hawley, L. R., Parker, B. J., Jones, S. T., Linderman, S., Galbraith, C. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.01.722235
The IL10 rs1800872 polymorphism differentially modulates the relationship between plasma IL-10 levels and cognitive function in methamphetamine use disorder
Liu, H., Ullah, S., Tian, Y., Jiang, L., Gang, X., Li, D., Zhang, X., & Wang, D. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111818
The effects of abused drugs on ferroptosis pathways: potential therapeutic targets for substance use disorders
Bouchard, T., Russell, B., Guo, L. L., Nguyen, T., Cheng, Y., Sanders, Y. Y., & Guo, M. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1899553
Time-Dependent Effects of Neonatal Methamphetamine Exposure on Catecholamines but Not Oxidative Stress in the Hippocampus and Striatum of Male Rats
Barbora, Č., Jana, J., Štefan, Z., Šimon, V., Šandera, Š., & Šlamberová, R. (2026) · Neurotoxicity Research · doi:10.1007/s12640-026-00828-9

Authors: Yamamoto, B. K., & Raudensky, J.
Affiliations: Boston University (US)
Corresponding author: Yamamoto, Bryan K.
ORCID: Yamamoto, Bryan K.
Venue: Journal of Neuroimmune Pharmacology
Publisher: Springer Science and Business Media LLC
Published: 2008-08-15
Volume: 3
Issue: 4
Pages: 203-217
ISSN: 1557-1890 (ISSN-L)
1557-1904
DOI: 10.1007/s11481-008-9121-7
PMC: PMC3955110
OpenAlex: W2135980918
Cited by: 167
References: 168
Citations by year: 2026: 5 · 2025: 12 · 2024: 6 · 2023: 6 · 2022: 18 · 2021: 10 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 10 · 2016: 10 · 2015: 8 · 2014: 12 · 2013: 12 · 2012: 16
FWCI: 1.09
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Journal of Neuroimmune Pharmacology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Drug Abuse (R01DA007606)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords: methamphetamine, MDMA, ecstasy, oxidative stress, mitochondrial dysfunction, neuroinflammation, dopaminergic neurons, serotonergic neurons, neuronal injury, neurotoxicity, drug abuse
MeSH terms: Amphetamines, Animals, Brain, Humans, Inflammation, Neurons, Illicit Drugs, Oxidative Stress

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Role of Oxidative Stress, Metabolic Compromise, and Inflammation in Neuronal Injury Produced by Amphetamine-Related Drugs of Abuse

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks